Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 14, 2006; 12(42): 6786-6791
Published online Nov 14, 2006. doi: 10.3748/wjg.v12.i42.6786
Published online Nov 14, 2006. doi: 10.3748/wjg.v12.i42.6786
Table 1 Characteristics in patients of refractry chronic hepatitis C
| Control | IFN | ACE-I | IFN+ACE-I | |
| No. of patients | 10 | 7 | 7 | 11 |
| Mean age ± SD (yr) | 60 ± 7 | 60 ± 9 | 58 ± 9 | 62 ± 8 |
| Sex (M/F) | 6/4 | 3/4 | 4/3 | 5/6 |
| Serum HCV-RNA1 (M copies/L) | 632 ± 120 | 641 ± 131 | 620 ± 106 | 628 ± 108 |
| Genotype (1 b/others) | 9/1 | 6/1 | 7/0 | 10/1 |
- Citation: Yoshiji H, Noguchi R, Kojima H, Ikenaka Y, Kitade M, Kaji K, Uemura M, Yamao J, Fujimoto M, Yamazaki M, Toyohara M, Mitoro A, Fukui H. Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C. World J Gastroenterol 2006; 12(42): 6786-6791
- URL: https://www.wjgnet.com/1007-9327/full/v12/i42/6786.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i42.6786